All filters
Slidesets
Perspectives on the Use of Endogenous Bio-markers to Assess Transporter Mediated Drug-Drug Interations_DDIs - Vikram Arya, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Novel Formulations and Devices - Charles Flexner, MD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
FDA Perspectives on COVID-19 Drug Development - Kimberly Struble, PharmaD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Emerging Infections and Biosecurity - Mohammed Lamorde, FRCP, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Clinical Pharmacology Long Acting ARVs - Marta Boffito, MD, PhD, FRCP
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020
Slidesets
Managing Highly Treatment-Experienced Patients - Prof. Anca Streinu Cercel -
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph Boesecke
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette Haberl
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
STI Diagnostics in the CEE Region - Pawel Jakubowski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
2020: Have We Reached the 90-90-90 Targets? - Teymur Noori
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
HIV and COVID-19 co-infection: An update Cristiana Oprea
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
PrEP Implementation in the CEE Region: What are the Successes, What are the Barriers? Prof. Milosz Parczewski
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Debate: Do Integrase Inhibitors and/or TAF Lead to Weight Gain? Con Standpoint - Jürgen Rockstroh
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Long-Acting Therapies: Which Patients Will Benefit Most? - Dr. Sharon Walmsley
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
Gilleece, Yvonne - The Management of Hepatitis in Pregnancy
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2020
Slidesets
FIND - Claude Mambo Muvunyi
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Hepatocellular carcinoma in Senegal epidemiological clinical and etiological aspects about 229 cases at hopital Principal de Dakar - Ibrahmia Diallo
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Hepatitis B awareness and perceptions among healthcare workers across africa report from the African hepatitis B network - Jose Debes
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Inclusion of vulnerable groups in HCV prevention testing and treatment in the African region - Niklas Luhmann
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Impact of covid-19 on the existing elimination programs - John Ward
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
nafld-nash_policies_and_practice_in_sub-saharan_africa_-_jeffrey_lazarus
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Prevalence of occult hepatitis C virus infection among Egyptian haemodialysis patients a single centre study - Tari George Michael
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020